Skip to main navigation Skip to search Skip to main content

A Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Effect of SAGE-718 in Parkinson's Disease Cognitive Impairment

Project: Research

Project Details

StatusFinished
Effective start/end date09/6/23 → 03/31/26

Funding

  • Sage Therapeutics Incorporated: $19,990.00